Welcome to LookChem.com Sign In|Join Free
  • or
2-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

692744-86-8

Post Buying Request

692744-86-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

692744-86-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 692744-86-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,2,7,4 and 4 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 692744-86:
(8*6)+(7*9)+(6*2)+(5*7)+(4*4)+(3*4)+(2*8)+(1*6)=208
208 % 10 = 8
So 692744-86-8 is a valid CAS Registry Number.

692744-86-8Relevant academic research and scientific papers

Novel one step synthesis of imidazo[1,2-a]pyridines and Zolimidine via iron/iodine-catalyzed Ortoleva-King type protocol

Ujwaldev, Sankuviruthiyil Mohanan,Rohit,Harry, Nissy Ann,Anilkumar, Gopinathan

, (2019)

Imidazo[1,2-a]pyridines form versatile scaffolds in pharmaceutical industry arising from their diverse biological activities. The synthesis of these molecules thus has been of great interest and resulted in the development of a large number of new methodologies. Herein we describe the first iron-catalyzed Ortoleva-King type protocol towards the synthesis of these fused heterocyclic compounds. This methodology employs cheap and easily available FeCl3·6H2O and molecular iodine as the catalytic system. The procedure has been well explored by extending the substrate scope with a variety of aromatic ketones and 2-aminopyridines to furnish different imidazo[1,2-a]pyridine derivatives in moderate to good yields. A successful application of this protocol was also demonstrated by achieving direct one step synthesis of the gastro protective drug, Zolimidine.

IMIDAZOPYRIDINE COMPOUNDS

-

Page/Page column 32, (2010/06/20)

The invention relates to compounds of formula (I): and their pharmaceutically acceptable salts and solvates, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 692744-86-8